Letter: placebo run-in for IBS clinical trials - is it useful? Authors' reply

被引：0
|
作者：
Hamatani, Tatsuto [1 ]
Fukudo, Shin [2 ]
Nakada, Yosuke [1 ]
Inada, Hiroshi [1 ]
Kazumori, Kiyoyasu [1 ]
Miwa, Hiroto [3 ]
机构：
[1] Sumitomo Dainippon Pharma Co Ltd, Osaka, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi, Japan
[3] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol, Nishinomiya, Hyogo, Japan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2020年 / 52卷 / 07期
关键词：
IRRITABLE-BOWEL-SYNDROME; OTILONIUM BROMIDE; DOUBLE-BLIND; EFFICACY; CONSTIPATION; LINACLOTIDE; EVALUATE; 12-WEEK;
D O I：
10.1111/apt.16047
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1239 / 1240
页数：2
相关论文
共 50 条
  • [21] Letter: all or nothing-placebo effects in a non-drug clinical trial in IBS. Reply
    Schumann, D.
    Cramer, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 106 - 107
  • [22] LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY
    Alton, E. W. F. W.
    Boyd, C.
    Cunningham, S.
    Davies, J. C.
    Hyde, S. C.
    Ianes, J. A.
    Gill, D. R.
    Greening, A.
    Griesenbach, U.
    Higgins, T.
    Porteous, D. J.
    THORAX, 2010, 65 : A11 - A11
  • [23] Why Has a Run-In Period Been a Design Element in Most Landmark Clinical Trials? Analysis of the Critical Role of Run-In Periods in Drug Development
    Packer, Milton
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (09) : 697 - 699
  • [24] Placebo run-in periods in anticholinergic trials are not associated with treatment effect size or risk of attrition: an empirical evaluation
    Karahalios, Amalia
    Herbison, G. Peter
    McKenzie, Joanne E.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020, 125 : 120 - 129
  • [25] Health services changes: is a run-in period necessary before evaluation in randomised clinical trials?
    Rathod, Trishna
    Belcher, John
    Montgomery, Alan A.
    Salisbury, Chris
    Foster, Nadine E.
    TRIALS, 2014, 15
  • [26] Need for a true placebo for vaginal microbicide efficacy trials -: Authors' reply
    Van Damme, L
    Rees, H
    Ramjee, G
    Laga, M
    Mâsse, B
    LANCET, 2003, 361 (9359): : 786 - 786
  • [27] Health services changes: is a run-in period necessary before evaluation in randomised clinical trials?
    Trishna Rathod
    John Belcher
    Alan A Montgomery
    Chris Salisbury
    Nadine E Foster
    Trials, 15
  • [28] Letter: meta-analysis of prebiotics, probiotics, synbiotics and antibiotics in IBS. Authors' reply
    Ford, Alexander C.
    Harris, Lucinda A.
    Lacy, Brian E.
    Quigley, Eamonn M. M.
    Moayyedi, Paul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (09) : 1254 - 1255
  • [29] Letter: a randomised clinical trial comparing the effects of pregabalin with those of placebo on functional dyspepsia. Authors' reply
    Thinrungroj, Nithi
    Kotikula, Isariyaphong
    Pinyopornpanish, Kanokwan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (11-12) : 1503 - 1504
  • [30] Authors’ Reply to Letter to the Editor: Neutral genetic diversity as a useful tool for conservation biology
    João C. Teixeira
    Christian D. Huber
    Conservation Genetics, 2021, 22 : 547 - 549
12345